Condition
Myeloproliferative Neoplasm (MPN) clinical trials and research
As of November 12, 2026, Find a Trial lists 3 Myeloproliferative Neoplasm (MPN) clinical trials that are recruiting, at sites in 2 countries (most in United States (2), Belgium (1)). By phase: Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 2Countries
Newest Myeloproliferative Neoplasm (MPN) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Identifying MPN-Specific Immune Targets in Blood and Bone Marrow | — | Brussels, Woluwe | Recruiting | May 15, 2026 |
| Thiotepa-based Conditioning With Reduced Post-Transplant Cyclophosphamide for Allogeneic Stem Cell Transplant in High-Risk Blood C cancers | Phase 1 | Pittsburgh, Pennsylvania | Recruiting | May 4, 2026 |
| Post-transplant cyclophosphamide strategies to prevent graft-versus-host disease after mismatched unrelated donor stem cell transplant | Phase 2 | Birmingham, Alabama and 12 other locations | Recruiting | Mar 5, 2025 |
All recruiting trials (3)
-
Identifying MPN-Specific Immune Targets in Blood and Bone Marrow
This study tests whether certain T cells in adults with MPN can recognize MPN cells and what antigens those T cells target.
-
Thiotepa-based Conditioning With Reduced Post-Transplant Cyclophosphamide for Allogeneic Stem Cell Transplant in High-Risk Blood C cancers
This phase 1 trial tests a Thiotepa, Busulfan, and Fludarabine conditioning regimen with de-escalated post-transplant cyclophosphamide to see if it can improve outcomes after allogeneic stem cell transplantation for high-risk blood cancers.
-
Post-transplant cyclophosphamide strategies to prevent graft-versus-host disease after mismatched unrelated donor stem cell transplant
This platform tests whether adding different drug combinations with post-transplant cyclophosphamide prevents graft‑versus‑host disease better than the standard regimen for adults getting mismatched unrelated donor peripheral blood stem cell transplants for blood cancers.
Related topics
Quick answers
How many Myeloproliferative Neoplasm (MPN) clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (2 trials), Belgium (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.